Premium
Low‐dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality
Author(s) -
Pan Pinhua,
Cardinal Jon,
Dhupar Rajeev,
Rosengart Matthew R.,
Lotze Michael T.,
Geller David A.,
Billiar Timothy R.,
Tsung Allan
Publication year - 2009
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1108713
Subject(s) - hmgb1 , sepsis , systemic administration , pharmacology , biology , lethality , inflammation , cytokine , immunology , in vitro , systemic inflammation , medicine , in vivo , toxicology , biochemistry , microbiology and biotechnology
Platinating agents in general, and cisplatin specifically, may be a novel candidate approach to the treatment of sepsis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom